Overview ArriVent Biopharma (https://arrivent.com/) is a clinical-stage biotechnology company based in Newtown Square, PA with 42 employees (Sep, 2023) developing targeted oncology therapies. The company was founded in 2021 with a $150 million Series A financing....
Hey, this is Mike from Amplion. In this video, I’ll provide a quick overview of how you can get more return on your investment in conferences. I’ll show you how to identify relevant contacts for the conference you’re attending and set up meetings in...
Major European pharmaceutical companies are conducting extensive preclinical research to identify and validate new drug targets and biomarkers across various cancer types. This early stage research is crucial to inform clinical development of novel oncology therapies....
Exciting oncology research is underway at several emerging European biopharmaceutical firms. Advances in cancer immunotherapies, antibody-drug conjugates, and combination therapies are highlighted in recent disclosures from these companies targeting both solid tumors...
Cancer remains one of the leading causes of death globally, with an estimated 10 million cancer deaths in 2020 alone. Major European pharmaceutical companies are continuously conducting clinical trials to develop innovative new cancer treatments and improve patient...
So far this year, Amplion has tracked 67 Seed and Series A investments into early-stage biotechs – down from 92 or a 27% decrease during the same period last year. That said, the biotech sector continues to witness rapid advancements, with numerous early-stage...
The research conducted by Pharma orgs across the globe in the field of gene therapy has brought forth significant advancements and potential benefits for patients with various genetic disorders and diseases. These pharmaceutical companies have contributed to expanding...
The emerging pharmaceutical industry plays a vital role in developing innovative treatments and therapies for various diseases. In 2023, several emerging pharmaceutical companies have made significant strides towards advancing their drug programs across a range of...
Advances in Cell Therapy in 2023: A Year of Promising Preclinical Studies Cell therapy has emerged as a groundbreaking field in medical science, offering innovative solutions for a range of diseases and conditions that were previously considered challenging to treat....
A number of emerging biopharma companies have announced significant funding rounds in recent months, as investors continue to bet on the potential of these early-stage firms to develop new therapies for a variety of diseases. Here are some of the top deals, along with...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
